SK33199A3 - Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases - Google Patents

Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases Download PDF

Info

Publication number
SK33199A3
SK33199A3 SK331-99A SK33199A SK33199A3 SK 33199 A3 SK33199 A3 SK 33199A3 SK 33199 A SK33199 A SK 33199A SK 33199 A3 SK33199 A3 SK 33199A3
Authority
SK
Slovakia
Prior art keywords
alkyl
group
aryl
tumor cells
mixture
Prior art date
Application number
SK331-99A
Other languages
English (en)
Slovak (sk)
Inventor
Dinanath F Rane
Alan K Mallams
Arthur G Taveras
F George Njoroge
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of SK33199A3 publication Critical patent/SK33199A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SK331-99A 1996-09-13 1997-09-11 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases SK33199A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71332696A 1996-09-13 1996-09-13
PCT/US1997/015900 WO1998011096A1 (en) 1996-09-13 1997-09-11 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

Publications (1)

Publication Number Publication Date
SK33199A3 true SK33199A3 (en) 1999-12-10

Family

ID=24865700

Family Applications (1)

Application Number Title Priority Date Filing Date
SK331-99A SK33199A3 (en) 1996-09-13 1997-09-11 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

Country Status (20)

Country Link
EP (1) EP0927178B1 (de)
JP (1) JP3152438B2 (de)
KR (1) KR20000036059A (de)
CN (1) CN1237169A (de)
AT (1) ATE213736T1 (de)
AU (1) AU729810B2 (de)
BR (1) BR9712819A (de)
CA (1) CA2264569C (de)
CZ (1) CZ83499A3 (de)
DE (1) DE69710741T2 (de)
ES (1) ES2169420T3 (de)
HU (1) HUP9904067A2 (de)
ID (1) ID22045A (de)
IL (1) IL128949A0 (de)
NO (1) NO991230L (de)
NZ (1) NZ334340A (de)
PL (1) PL332240A1 (de)
SK (1) SK33199A3 (de)
TR (1) TR199900561T2 (de)
WO (1) WO1998011096A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999037619A1 (en) 1998-01-21 1999-07-29 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
ATE309249T1 (de) 1998-01-21 2005-11-15 Millennium Pharm Inc Chemokin rezeptor antagonisten und verwndung
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
US7417026B2 (en) 2003-08-13 2008-08-26 Children's Hospital Medical Center Mobilization of hematopoietic cells
US7550478B2 (en) 2005-06-23 2009-06-23 Merck & Co. Inc. Tyrosine kinase inhibitors
TW200813021A (en) 2006-07-10 2008-03-16 Merck & Co Inc Tyrosine kinase inhibitors
TW201024283A (en) * 2008-12-01 2010-07-01 Targacept Inc Synthesis and novel salt forms of (R)-3-((E)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine
JP6959332B2 (ja) 2016-09-27 2021-11-02 ミッション セラピューティクス リミティド Ｕｓｐ３０の阻害剤としての活性を有するシアノピロリジン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG48750A1 (en) * 1993-10-15 1998-05-18 Schering Corp Tricyclic carbonate compounds useful for inhabition of g-protein function for treatment of proliferative diseases
EP0723539B1 (de) * 1993-10-15 2001-12-12 Schering Corporation Tricyclische sulfonamide-derivate zur inhibierung der g-protein funktion und fur die bekandlung von proliferativen erkrantungen
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them

Also Published As

Publication number Publication date
KR20000036059A (ko) 2000-06-26
JP3152438B2 (ja) 2001-04-03
IL128949A0 (en) 2000-02-17
CA2264569C (en) 2003-11-11
JP2000502727A (ja) 2000-03-07
ATE213736T1 (de) 2002-03-15
EP0927178B1 (de) 2002-02-27
AU4337397A (en) 1998-04-02
ID22045A (id) 1999-08-26
DE69710741T2 (de) 2002-10-24
NZ334340A (en) 2000-09-29
ES2169420T3 (es) 2002-07-01
DE69710741D1 (de) 2002-04-04
HUP9904067A2 (hu) 2000-05-28
PL332240A1 (en) 1999-08-30
BR9712819A (pt) 1999-11-23
AU729810B2 (en) 2001-02-08
EP0927178A1 (de) 1999-07-07
CA2264569A1 (en) 1998-03-19
CZ83499A3 (cs) 1999-07-14
WO1998011096A1 (en) 1998-03-19
NO991230L (no) 1999-05-14
NO991230D0 (no) 1999-03-12
CN1237169A (zh) 1999-12-01
HK1018267A1 (en) 1999-12-17
TR199900561T2 (xx) 1999-06-21

Similar Documents

Publication Publication Date Title
ES2235252T3 (es) Inhibidores triciclicos de la farnesil proteina transferasa.
WO1998057946A1 (en) Carboxy piperidylacetamide tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases (farnesyl protein transferase inhibitors)
EP0927178B1 (de) Tricyclische verbindungen zur inhibierung der g-protein funktion und für die behandlung von proliferativen erkrankungen
EP0934303B1 (de) Trizyklische verbindungen mit farnesyl protein transferase inhibierender wirkung
CA2293712C (en) Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
SK33599A3 (en) Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase
WO1998057947A1 (en) Tricyclic keto amide derivatives useful as farnesyl protein transferase inhibitors
US5958890A (en) Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
CA2293373C (en) Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
ES2205255T3 (es) Derivados de benzocicloheptapiridina sustituida utiles para inhibir la farnesil-protein-transferasa.
CA2293549C (en) Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
CA2264511C (en) Compounds useful for inhibition of farnesyl protein transferase
HK1018267B (en) Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
MXPA99012066A (en) Benzo(5,6)cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors